Depression Treatment with Ketamine Therapy in Connecticut
Struggling with depression that hasn’t improved with medication? Ketamine therapy offers a fast-acting alternative for treatment-resistant depression
What Is Depression (Major Depressive Disorder)?
Depression, also known as Major Depressive Disorder (MDD), is a serious mental health condition that affects mood, behavior, and overall well-being. Individuals with depression may experience persistent sadness, fatigue, low motivation, difficulty concentrating, and a loss of interest in daily activities.
For some, depression can become treatment-resistant, meaning symptoms do not improve despite the use of antidepressants or therapy. This can significantly impact quality of life, relationships, and daily functioning. In these cases, alternative treatments such as ketamine therapy may offer a fast-acting option that may help provide relief and support individuals who have not responded to traditional approaches.
Gino Ang, MD, and the experienced team at Ketamine Center of Connecticut provide IV ketamine infusions designed for individuals struggling with depression that hasn’t improved with antidepressants or traditional therapy. This fast-acting treatment targets treatment-resistant depression and may help relieve symptoms when other options have failed.
What many patients experience as symptoms begin to lift
Many patients report a noticeable easing of suicidal ideation within hours as the treatment helps interrupt the intense negative thought cycles often associated with severe depression. While individual responses vary, early relief can provide a crucial window of clarity and stability, allowing patients to re-engage with support, therapy, and a broader treatment plan.
Many patients experience a measurable reduction in intense sadness as ketamine begins to modulate glutamate pathways involved in mood regulation. This early shift can help reduce the weight of hopelessness and create space for improved functioning, even though full therapeutic effects may continue developing over subsequent sessions.
As ketamine influences neural pathways involved in reward and motivation, many patients begin to regain the capacity to experience interest and enjoyment in daily activities. This improvement often reflects early restoration of normal brain signaling rather than a sudden emotional shift, and may continue to strengthen as treatment progresses.
Ketamine’s impact on key neurotransmitter systems can lead to a noticeable reduction in physiological anxiety, including restlessness and persistent racing thoughts. Many patients report a calmer baseline as acute anxiety responses begin to settle, which can support clearer thinking and improved participation in ongoing treatment and daily activities.
As ketamine disrupts rigid neural patterns linked to obsessive or repetitive thinking, many patients experience a reduction in the intensity and frequency of these negative cognitive cycles. Doubt‑driven checking and repetitive mental loops often become less dominant, allowing for more flexible, balanced thought processes to emerge.
By influencing neural circuits involved in rumination, ketamine can reduce the intensity and persistence of repetitive negative thinking. Many patients notice that self‑critical patterns become less intrusive, creating space for clearer, more adaptive cognitive responses as treatment continues.
As ketamine begins to rebalance mood‑related neural pathways, many patients experience a gradual increase in energy and task‑initiation ability. Even small actions may feel more manageable, reflecting improved cognitive activation rather than a sudden boost in drive. This shift can support greater engagement in daily routines and ongoing therapeutic work.
Learn more about what to expect on your journey.
Frequently Asked Questions
Everyone has the blues now and again, and they know that their mood eventually improves and they feel better. Many people believe that depression goes away just as easily as the blues, but it doesn’t.
- Feel worthless and hopeless
- Lack energy nearly every day
- Have no interest in your activities or friends
- Eat too little or too much
- Sleep too little or too much
- Find it hard to concentrate
- Feel restless
- Think about suicide or death
Postpartum depression is not just the baby blues. It’s a type of major depression that occurs during pregnancy or after childbirth and, like major depression, it doesn’t improve on its own.
Your depression is treatment-resistant when your symptoms don’t improve after at least two trials of antidepressant medications. Many patients with depression don’t feel better even after taking four different types of antidepressants.
Ketamine has been safely used for decades as an anesthetic during surgical procedures. In a low dose, however, ketamine has a different effect: It relieves the symptoms of depression, even in patients with treatment-resistant depression.
The anesthesiologists at Ketamine Center of Connecticut give you an intravenous (IV) infusion of ketamine using a pump that precisely delivers the right dose. They also continuously monitor your heart rate and blood pressure using a wireless device called Caretaker®.
Honest reviews from people who discovered a new path to wellness
Why Choose Us?







Your struggles are real. So are the solutions we provide.
What can we help you with?
Overcome Depression
Most patients with depression count on medications like antidepressants to improve their mood, yet antidepressants fail to…
Conquer Anxiety
Nearly one-third of adolescents and adults have an anxiety disorder, yet only half of them improve with standard…
Heal from PTSD
Post-traumatic stress disorder (PTSD) has a devastating impact on people of all ages, including about 8% of adults and…
Break Free from OCD
Obsessive-compulsive disorder (OCD) causes unwanted but uncontrollable thoughts and behaviors that disrupt your…
Heal from Bipolar
Bipolar disorder often begins with an episode of major depression before you cycle to mania. In many patients, bipolar depression…
Overcome Suicidality
In 2017, Connecticut officials reported that suicide was the second leading cause of death for people between the ages of…